Glenmede Trust’s Vanguard S&P Mid-Cap 400 Growth ETF IVOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-484
Closed -$47.5K 1365
2023
Q4
$47.5K Hold
484
﹤0.01% 1229
2023
Q3
$43.7K Sell
484
-968
-67% -$90.9K ﹤0.01% 1183
2023
Q2
$129K Hold
1,452
﹤0.01% 1143
2023
Q1
$129K Hold
1,452
﹤0.01% 1149
2022
Q4
$123K Hold
1,452
﹤0.01% 1135
2022
Q3
$114K Hold
1,452
﹤0.01% 1130
2022
Q2
$114K Sell
1,452
-268
-16% -$23.4K ﹤0.01% 1143
2022
Q1
$165K Buy
+1,720
New +$165K ﹤0.01% 1155
2020
Q4
Sell
-84
Closed -$6K 1729
2020
Q3
$6K Hold
84
﹤0.01% 2046
2020
Q2
$5K Hold
84
﹤0.01% 2075
2020
Q1
$6K Hold
84
﹤0.01% 2619
2019
Q4
$6K Hold
84
﹤0.01% 2619
2019
Q3
$5 Hold
84
﹤0.01% 2631
2019
Q2
$5 Hold
84
﹤0.01% 2623
2019
Q1
$5 Hold
84
﹤0.01% 2608
2018
Q4
$4 Buy
+84
New +$5.45K ﹤0.01% 2605
2018
Q2
Sell
-84
Closed -$5K 2122
2018
Q1
$5K Hold
84
﹤0.01% 2398
2017
Q4
$5K Buy
+84
New +$5.49K ﹤0.01% 2398

Other funds holding IVOG

Glenmede Trust's IVOG Position: Q1 2024 in Review

Glenmede Trust sold out of Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) in Q1 2024, closing a stake of 484 shares — an estimated $47.5K sold.

Glenmede Trust first reported a position in IVOG in Q4 2017 and held it in 18 quarters. The position peaked at $165K in Q1 2022. 122 funds tracked by Wall St. Rank hold IVOG as of Q1 2024.

  • Glenmede Trust reported no remaining Vanguard S&P Mid-Cap 400 Growth ETF position as of Q1 2024 after selling out during the quarter.
  • Glenmede Trust sold 484 Vanguard S&P Mid-Cap 400 Growth ETF shares in Q1 2024, an estimated $47.5K.
  • Glenmede Trust first reported a position in Vanguard S&P Mid-Cap 400 Growth ETF in Q4 2017 and held it in 18 quarters.
  • Glenmede Trust's Vanguard S&P Mid-Cap 400 Growth ETF position peaked at $165K in Q1 2022.
  • 122 funds tracked by Wall St. Rank held Vanguard S&P Mid-Cap 400 Growth ETF as of Q1 2024.

Based on Glenmede Trust's 13F filing for Q1 2024, filed 15 May 2024.